Leading Scientists to Present Computational and Informatics Solutions at Accelrys Science Forum Series
News Oct 10, 2007
Innovative science and technology will be the focus of a major seminar series by Accelrys, Inc., a provider of scientific modeling and workflow software solutions.
The seminar series us expected to provide a look at the most recent developments in modeling and simulation, informatics and data integration analysis and reporting and will feature presentations by scientists from industry, academia and Accelrys. The event is free for registrants and will be held at locations throughout the US and Europe.
Science Forum dates and locations in the US include: October 23: Boston, Massachusetts, October 25: Princeton, New Jersey, October 30: San Diego, CA, November 13: Houston, Texas, (Note: Chemicals/Materials only) November 15: San Francisco, California.
The seminar features tracks for Pharmaceutical and Biotechnology Research, Chemicals and Materials R&D, and Platform, Informatics, and Reporting. Topics in the Pharmaceutical and Biotechnology track include rational flexible docking, QM/MM, pk predictions for proteins, antibody modeling and docking, and de novo fragment-based design.
In the Chemicals/Materials track topics include catalysis, nanotechnology, crystallization, and QSAR. Topics in the Platform and Informatics track include enterprise and desktop cheminformatics solutions, reporting and drill-down dashboards, high content analysis, and web service & application development within an SOA environment.
Accelrys customers and potential customers will also have the opportunity to see and use recent Accelrys product releases including Discovery Studio 2.0, Materials Studio 4.2 and Pipeline Pilot 6.1 as part of the hands-on workshop included in the forum.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE